Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 13, Number 11—November 2007
Dispatch

Human Multidrug-Resistant Salmonella Newport Infections, Wisconsin, 2003–2005

Amy E. Karon*1Comments to Author , John R. Archer†, Mark J. Sotir*†1, Timothy A. Monson‡, and James J. Kazmierczak*†
Author affiliations: *University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA; †Wisconsin Division of Public Health, Madison, Wisconsin, USA; ‡Wisconsin State Laboratory of Hygiene, Madison, Wisconsin, USA;

Main Article

Figure

Antimicrobial drug resistance patterns of human Salmonella Newport isolates from Wisconsin (2003–2005) and elsewhere in the United States (2003–2004), based on data provided by the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). 2005 NARMS data were not available at the time of publication of this report. Antimicrobial subclasses are as defined by the Clinical and Laboratory Standards Institute (9). SC, subclass; M*, MDRAmpC.

Figure. Antimicrobial drug resistance patterns of human Salmonella Newport isolates from Wisconsin (2003–2005) and elsewhere in the United States (2003–2004), based on data provided by the National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS). 2005 NARMS data were not available at the time of publication of this report. Antimicrobial subclasses are as defined by the Clinical and Laboratory Standards Institute (9). SC, subclass; M*, MDRAmpC.

Main Article

References
  1. Gupta  A, Fontana  J, Crowe  C, Bolstorff  B, Stout  A, Van Duyne  A, Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States. J Infect Dis. 2003;188:1707–16. DOIPubMedGoogle Scholar
  2. Centers for Disease Control and Prevention. National Antimicrobial Resistance Monitoring System for Enteric Bacteria (NARMS): 2003 human isolates final report. Atlanta: US Department of Health and Human Services, the Centers; 2006.
  3. Guerrant  RL, Van Gilder  T, Steiner  TS, Thielman  NM, Slutsker  L, Tauxe  RV, Practice guidelines for the management of infectious diarrhea. Clin Infect Dis. 2001;32:331–51. DOIPubMedGoogle Scholar
  4. Centers for Disease Control and Prevention. Outbreak of multidrug-resistant Salmonella Newport—United States, January–April 2002. MMWR Morb Mortal Wkly Rep. 2002;51:545–8.PubMedGoogle Scholar
  5. Rankin  SC, Aceto  H, Cassidy  J, Holt  J, Young  S, Love  B, Molecular characterization of cephalosporin-resistant Salmonella enterica serotype Newport isolates from animals in Pennsylvania. J Clin Microbiol. 2002;40:4679–84. DOIPubMedGoogle Scholar
  6. Varma  JK, Marcus  R, Stenzel  SA, Hanna  SS, Gettner  S, Anderson  BJ, Highly resistant Salmonella Newport-MDRAmpC transmitted through the domestic US food supply: a FoodNet case-control study of sporadic Salmonella Newport infections, 2002–2003. J Infect Dis. 2006;194:222–30. DOIPubMedGoogle Scholar
  7. United States Department of Agriculture. 2002 census of agriculture–volume 1 geographic area series census, US—state data [cited 2007 Feb 26]. Available from http://www.nass.usda.gov/Census/Create_Census_US.jsp#top.
  8. Centers for Disease Control and Prevention. Salmonella Surveillance Summary, 2002 [cited 2007 Aug 20]. Atlanta: US Department of Health and Human Services, The Centers, 2003. Available from http://www.cdc.gov/NCIDOD/DBMD/phlisdata/salmtab/2002/SalmonellaIntroduction2002
  9. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement, M100–S16. Wayne (PA): The Institute; 2006.
  10. Winokur  PL, Vonstein  DL, Hoffman  LJ, Uhlenhopp  EK, Doern  GV. Evidence for transfer of CMY-2 AmpC beta-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother. 2001;45:2716–22. DOIPubMedGoogle Scholar
  11. Zwald  AG, Ruegg  PL, Kaneene  JB, Warnick  LD, Wells  SJ, Fossler  C, Management practices and reported antimicrobial usage on conventional and organic dairy farms. J Dairy Sci. 2004;87:191–201. DOIPubMedGoogle Scholar
  12. Alcaine  SD, Sukhnanand  SS, Warnick  LD, Su  WL, McGann  P, McDonough  P, Ceftiofur-resistant Salmonella strains isolated from dairy farms represent multiple widely distributed subtypes that evolved by independent horizontal gene transfer. Antimicrob Agents Chemother. 2005;49:4061–7. DOIPubMedGoogle Scholar
  13. Lopes  VC, Wedel  SD, Bender  JB, Smith  KE, Leano  FT, Boxrud  DJ, Emergence of multidrug-resistant Salmonella enterica serovar Newport in Minnesota. Clin Infect Dis. 2006;43:210–3. DOIPubMedGoogle Scholar
  14. Cobbold  RN, Rice  DH, Davis  MA, Besser  TE, Hancock  DD. Long-term persistence of multidrug-resistance Salmonella enterica serovar Newport in two dairy herds. J Am Vet Med Assoc. 2006;228:585–91. DOIPubMedGoogle Scholar
  15. Devasia  RA, Varma  JK, Whichard  J, Gettner  S, Cronquist  AB, Hurd  S, Antimicrobial use and outcomes in patients with multi-drug resistant and pansusceptible Salmonella Newport infections, 2002–2003. Microb Drug Resist. 2005;11:371–7. DOIPubMedGoogle Scholar

Main Article

1Current affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Page created: July 04, 2010
Page updated: July 04, 2010
Page reviewed: July 04, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external